Tools commonly used in the Nuclear Medicine Supplies & Acces (Manufacturing) industry for day-to-day tasks and operations.

• Cyclotron
• Radioisotope generator
• Hot cell
• Dose calibrator
• Gamma counter
• Liquid scintillation counter
• High-performance liquid chromatography (HPLC)
• Gas chromatography (GC)
• Mass spectrometer
• Radioactivity detector

Common products and services typical of NAICS Code 325412-14, illustrating the main business activities and contributions to the market.

• Radiopharmaceuticals
• Technetium-99m generators
• Iodine-131 capsules
• Fluorodeoxyglucose (FDG)
• Strontium-89 chloride
• Samarium-153 lexidronam
• Lutetium-177 dotatate
• Yttrium-90 ibritumomab tiuxetan
• Radium-223 dichloride
• Gallium-68 dotatate

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• Nuclear Regulatory Commission (NRC) License: A license issued by the NRC to facilities that manufacture, distribute, or use radioactive materials in nuclear medicine. The license ensures that the facility complies with safety regulations and procedures for handling radioactive materials.
• Good Manufacturing Practice (GMP) Certification: A certification that ensures that the manufacturing process of nuclear medicine supplies and accessories meets the quality standards set by the FDA. The certification is issued by the FDA.
• United States Pharmacopeia (USP) Certification: A certification that ensures that the nuclear medicine supplies and accessories meet the quality standards set by the USP. The certification is issued by the USP.
• Environmental Protection Agency (EPA) Permit: A permit that is required for facilities that generate, store, or dispose of radioactive waste. The permit ensures that the facility complies with environmental regulations for handling radioactive waste.
• Occupational Safety and Health Administration (OSHA) Certification: A certification that ensures that the facility complies with safety regulations and procedures for handling radioactive materials. The certification is issued by OSHA.

A concise historical narrative of NAICS Code 325412-14 covering global milestones and recent developments within the United States.

• The Nuclear Medicine Supplies & Access (Manufacturing) industry has a relatively short history, dating back to the 1950s when the first nuclear medicine procedures were developed. The industry has since grown to become an essential part of modern medicine, with the development of new technologies and advancements in radiopharmaceuticals. Notable milestones include the development of the first gamma camera in the 1960s, the introduction of positron emission tomography (PET) in the 1970s, and the development of single-photon emission computed tomography (SPECT) in the 1980s. In recent years, the industry has seen significant growth due to the increasing demand for nuclear medicine procedures and the development of new radiopharmaceuticals. In the United States, the Nuclear Medicine Supplies & Access (Manufacturing) industry has experienced steady growth over the past few decades. The industry has benefited from advancements in technology, such as the development of new radiopharmaceuticals and imaging equipment, as well as an aging population that requires more medical procedures. The industry has also faced challenges, such as regulatory changes and the rising cost of healthcare. Despite these challenges, the industry is expected to continue to grow in the coming years, driven by the increasing demand for nuclear medicine procedures and the development of new technologies.

The anticipated future trajectory of the NAICS 325412-14 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Growing

  The future outlook for the Nuclear Medicine Supplies & Access (Manufacturing) industry in the USA is positive. The industry is expected to grow due to the increasing demand for nuclear medicine procedures, which are used for the diagnosis and treatment of various diseases. The aging population in the USA is also expected to contribute to the growth of the industry, as older people are more likely to require medical imaging and nuclear medicine procedures. Additionally, advancements in technology and the development of new radiopharmaceuticals are expected to drive growth in the industry. However, the industry may face challenges such as regulatory hurdles and the high cost of research and development.

Recent groundbreaking advancements and milestones in the Nuclear Medicine Supplies & Acces (Manufacturing) industry, reflecting notable innovations that have reshaped its landscape.

• Northstar Medical Radioisotopes: The company has developed a technology to produce the medical radioisotope molybdenum-99 (Mo-99) without using highly enriched uranium (HEU), which is a significant milestone in the industry.
• Radiogenix System: The RadioGenix System is a new technology that allows for the production of technetium-99m (Tc-99m), which is used in over 80% of all nuclear medicine procedures, without the use of nuclear reactors.
• Gallium-68 (Ga-68) Generator: The Ga-68 generator is a new technology that allows for the production of Ga-68, which is used in PET imaging, on-site at hospitals and clinics.
• Targeted Alpha Therapy: Targeted Alpha Therapy is a new type of cancer treatment that uses alpha particles to destroy cancer cells while minimizing damage to healthy cells.
• Cyclotron Production Of Radioisotopes: Cyclotron production of radioisotopes is a new technology that allows for the production of a wide range of medical radioisotopes on-site at hospitals and clinics, reducing the need for centralized production facilities.